CATALYST PHARMACEUTICALS, INC.CPRXBalance sheet

Market cap
$2.8B
P/E ratio
2011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/12
Cash and cash equivalents 61292814571790130171298138518
Marketable securities, current -817262627273751020---
Total cash & short-term investments6920365540845395140191298138518
Accounts receivable, net--------1167105465
Inventories-------56,01225871620
Total current assets617254460418555111159210321219624
Property, plant and equipment, net12,18653,67940,62871,377191,549244,204191,385245,425210,467129,8001111
Marketable securities, non-current -------5------
Total non-current assets21,07462,56749,51680,265200,437253,092200,27351332855251228
Total assets 617254460428560112192238376470851
Accounts payable263,9341850,78922933,1762244341517
Total current liabilities833,801226324102423275876121
Total non-current liabilities2520,465231303,388157,456154,799647,532-41863
Total liabilities 2249524102523317582124
Common stock and paid-in capital 425776105146147208211216223233251267442
Retained earnings-38,102,617-42,179,003-54,333,599-69,842,660-90,075,618-108,148,070-126,560,447-160,563,961-128,688,624-53,705,624-2650121285
Stockholders' equity41521355539815188170207300388728
Working capital--------